top of page

Best Bone Marrow Transplant Hospitals in China: 4 to Compare

By

ChinaCureLink

Tue Nov 17 2026

8 min read

1 day ago
8 min read

Medically reviewed by Dr Eric Wang- ChinaCureLink Team


Four bone marrow transplant hospitals in China to compare are Peking University People’s Hospital, West China Hospital, Yanda Lu Daopei Hospital, and the Second Affiliated Hospital of Chongqing Medical University. Start with the team that treats your diagnosis and offers the donor pathway you need. A patient with acute leukemia considering a half-matched family donor has different priorities from a patient with myeloma considering a transplant using their own cells. Ask for outcomes in patients with a similar diagnosis, disease status and donor type.

Key Takeaways

• Confirm whether the proposed transplant uses your own cells or a donor’s cells.

• Ask about outcomes for your diagnosis, disease status, age and donor type.

• Half-matched relatives can expand donor options for eligible patients.

• Get an itemized estimate and a written plan for complications and follow-up.


Table of Contents


Which Type of Transplant Do You Need?


Bone marrow transplant is a common name for hematopoietic stem cell transplantation (HSCT). The cells can come from marrow, circulating blood or banked umbilical cord blood. In an autologous transplant, your own stored cells restore blood production after high-dose treatment. This approach is used in selected patients with myeloma or lymphoma. An allogeneic transplant uses donor cells. It may be considered for selected patients with leukemia, myelodysplastic syndromes or severe aplastic anemia. NCI, Stem Cell and Bone Marrow Transplants for Cancer · Chinese Society of Hematology, severe aplastic anemia transplant guidelines


For leukemia, ask whether the disease is in remission and what measurable residual disease (MRD) testing found. MRD testing looks for cancer cells that remain below the detection threshold of standard exams. For severe aplastic anemia, ask whether transplant or immune-suppressing treatment is appropriate given your age, donor options and other health conditions. Chinese Society of Hematology, severe aplastic anemia transplant guidelines


What China Has Contributed to Transplant Care


Peking University’s hematology team helped develop the Beijing protocol for transplantation from a half-matched relative. This approach can expand donor options when a fully matched donor is unavailable. Chinese transplant teams also use other approaches to reduce graft-versus-host disease (GVHD), a complication in which donor immune cells attack the patient’s tissues. A Chinese registry analysis compared three half-matched transplant protocols. Because the study was retrospective, differences between patients and centres can influence outcomes. Chinese registry comparison of three haploidentical protocols · ClinicalTrials.gov NCT05629260


A 2024 Chinese registry study followed 76 transplant recipients aged 50 or older with severe aplastic anemia. Among the 55 who received a half-matched donor transplant, estimated three-year overall survival was 71.8%. The study was retrospective and involved selected patients who reached transplant. The estimate cannot predict the outcome of a younger patient, a patient with leukemia, or someone with different medical risks. Haematologica, 2024 Chinese registry study


Donor transplantation is established care for specific indications. A centre may also offer clinical research involving a new conditioning regimen, donor strategy or cell product. Ask which parts of the plan are standard and which require trial consent. The guide to clinical trials in China for foreigners explains how to check access.



Four Bone Marrow Transplant Hospitals to Compare


These hospitals were selected for documented hematopoietic stem cell transplant programs. Comparable, risk-adjusted results for the same diagnosis and donor type would be needed to rank them by outcomes.


Peking University People’s Hospital — Beijing


The Peking University Institute of Hematology at this hospital developed the Beijing protocol for half-matched donor transplantation. Its team also sponsors a registered study on optimizing half-matched transplantation. Ask which donor and GVHD prevention approach the team would propose for your diagnosis. Chinese registry comparison of three haploidentical protocols · ClinicalTrials.gov NCT05629260 · Peking University People’s Hospital hematology profile


Peking University People’s Hospital exterior, featured among bone marrow transplant hospitals in China

Beijing · Public university hospital

Donor transplant · Half-matched donors · Hematology research

Selection basis: development of the Beijing protocol

Known for: Peking University Institute of Hematology and its half-matched donor transplant program.

Official Information


West China Hospital, Sichuan University — Chengdu


West China Hospital documents experience with both autologous and donor transplants, including half-matched and cord-blood pathways. It is a relevant centre to ask about alternatives when a fully matched donor is unavailable, or when the decision is whether to use your own cells. Confirm the treating campus before making arrangements. West China Hospital hematology department


West China Hospital, Sichuan University exterior, featured among bone marrow transplant hospitals in China

Chengdu · Public university hospital

Autologous transplant · Allogeneic transplant · Cord blood

Selection basis: documented range of graft and donor options

Known for: A hematology service reporting matched, unrelated, half-matched and cord-blood transplant experience.

Official Information


Yanda Lu Daopei Hospital — Sanhe, Hebei


Yanda Lu Daopei Hospital publishes information on its dedicated transplant department. Its focused hematology setting gives patients a private option to compare with the three public university hospitals. Ask for outcomes for your exact diagnosis and age group, the campus where treatment would take place, and access to intensive care and infection specialists. Yanda Lu Daopei Hospital transplant department


Yanda Lu Daopei Hospital exterior, featured among bone marrow transplant hospitals in China

Sanhe, Hebei · Private hematology hospital

Hematology · Donor transplant · Dedicated transplant department

Selection basis: dedicated stem cell transplant department

Known for: A private hospital with a dedicated hematopoietic stem cell transplant department.

Official Information


For Fuda, Modern, Concord and RoyalLee, an oncology service listing alone is insufficient to verify a comparable donor transplant program. Request the named transplant unit, graft sources, emergency coverage and outcomes before comparing a package.


Second Affiliated Hospital of Chongqing Medical University — Chongqing


The hospital’s hematology department lists hematopoietic stem cell transplantation among its specialties. Its team published a case of a half-matched donor transplant for severe aplastic anemia following chemotherapy. Ask the centre about experience with your diagnosis and donor type, and confirm the treating campus. Published Chongqing transplant case


Second Affiliated Hospital of Chongqing Medical University exterior, featured among bone marrow transplant hospitals in China

Chongqing · Grade 3A public university hospital

Hematology · Donor transplant · Aplastic anemia

Selection basis: documented hematopoietic stem cell transplant service

Known for: A hematology department designated as a Chongqing transplant centre by the Chinese Marrow Donor Program.

Official Information


How to Compare a Chinese Transplant Plan With Care at Home


Ask both teams to explain the indication, donor choice, conditioning intensity and GVHD prevention. A matched sibling, a matched unrelated donor, a half-matched relative and cord blood can all be options in selected settings. Their relative suitability depends on the disease and patient. A transplant team should explain why it prefers a particular donor and how long the search or collection may take. NCI, Stem Cell and Bone Marrow Transplants for Cancer · Chinese Society of Hematology, severe aplastic anemia transplant guidelines · Chinese registry comparison of three haploidentical protocols · ClinicalTrials.gov NCT05629260


Request the centre’s recent results for patients comparable to you. Ask for the number of patients, period of treatment, overall survival, relapse, graft failure, severe GVHD and deaths unrelated to relapse. For a child, ask specifically about pediatric experience and long-term follow-up for growth and development. NCI Pediatric HSCT and Cellular Therapy PDQ


Compare access to urgent care after discharge. A hospital overseas may offer a suitable donor strategy, while a local team may be better placed to manage prolonged follow-up. Arrange a handover before travel and keep the home team involved in decisions about timing.


Eligibility, Costs, and International Patient Access


Send the pathology and marrow reports, molecular and chromosome tests, treatment history, latest disease assessment, recent blood counts and any HLA typing already available. HLA typing checks tissue compatibility between patient and donor. The transplant team will review infections, organ function, ability to tolerate conditioning and donor suitability. It should also confirm whether your donor can be assessed and collected locally. NCI, Stem Cell and Bone Marrow Transplants for Cancer · Chinese Society of Hematology, severe aplastic anemia transplant guidelines


Ask for a written estimate covering donor testing and collection, conditioning, admission, cell processing, transfusions, medicines and post-discharge monitoring. Ask separately about intensive care, GVHD treatment, graft failure and a longer-than-expected stay. Published cancer treatment costs in China can help with budgeting. A transplant-specific quote must come from the hospital.


Before booking travel, confirm three points in writing: that the hospital can review overseas patients and donors, what translated records it requires, and how long you and your caregiver should remain nearby. Ask who will manage fever, infection or suspected GVHD after you return. Plan travel to China for medical treatment around the transplant team’s timetable.


Independent Guidance Before Booking


ChinaCureLink, a Medebound HEALTH company, can organize records for review and help identify teams that handle your diagnosis and donor situation. Hospital and specialist matching is free. Video second opinions are paid specialist consultations, with fees confirmed before booking. The hospital determines eligibility and donor suitability.


Use ChinaCureLink hospital matching to compare proposed pathways before traveling. If you proceed, ask for a separate quote for on-site coordination.


Contacting Hospitals Directly vs. ChinaCureLink


Both routes can work. The treating hospital decides medical suitability; facilitation helps organize the assessment and practical arrangements.




Practical Next Steps Before Travel


1. Confirm the diagnosis and transplant indication. 2. Review the disease status and donor search. 3. Compare teams treating similar patients. 4. Get a specialist opinion and written estimate. 5. Agree on an emergency plan and follow-up with your home team.


The best fit depends on who can deliver your proposed transplant and support recovery. Review the full pathway with a transplant specialist before committing to travel.


Get a Second Opinion


For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.



A Published Pediatric Transplant Case


A 2025 report from the Affiliated Hospital of Qingdao University described a three-year-old with acquired severe aplastic anemia whose first two unrelated-donor grafts failed. A third transplant from a half-matched donor achieved durable engraftment, meaning the donated cells continued to produce blood cells. The authors reported five years of follow-up. Li et al., Frontiers in Immunology, July 9, 2025


Two graft failures preceded that outcome. This individual experience cannot estimate the chance of success or establish the best donor for another child. Families facing graft failure need a specialist review of its cause, donor options and the risks of another transplant.


Donor cell recovery across three transplants in one pediatric patient

Figure 1 from Li et al. (2025), showing donor cell recovery across three transplants in one patient. Reproduced under CC BY 4.0. Primary source · CC BY 4.0


What Patients Say About ChinaCureLink & Medebound HEALTH


These are general experiences of care coordination, not evidence of transplant outcomes.


General patient-service testimonials for international patients researching bone marrow transplant hospitals in China

China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.



Frequently Asked Questions


Which bone marrow transplant hospitals in China should I compare?

Peking University People’s Hospital in Beijing, West China Hospital in Chengdu, Yanda Lu Daopei Hospital in Hebei, and the Second Affiliated Hospital of Chongqing Medical University have documented transplant programs. Choose according to diagnosis, age, donor options and the team’s experience with comparable patients.


Can a parent or child donate stem cells?

A parent or child may be a half-matched donor. The transplant team must confirm HLA compatibility, donor health, and suitability for the proposed transplant.


Can international patients get a bone marrow transplant in China?

Ask the centre to confirm patient and donor acceptance, required tests, availability, a written estimate and the follow-up plan. Each case needs review before booking travel.



About ChinaCureLink


ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.


We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.


ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.


References



Hospital photographs depict the named institutions. Case figure credit: Li et al., Frontiers in Immunology (2025), CC BY 4.0.


Disclaimer


This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.


You may also like:


bottom of page